Regulatory and Washington

The INFORM Consumers Act targets organized retail crime and would shed light on certain sellers by requiring online retailers to verify high-volume sellers.

The Food and Drug Administration has requested that manufacturers withdraw all prescription and OTC ranitidine drugs from the market immediately.

A new bill introduced by Sens. Bill Cassidy, R-La., and Dick Durbin, D-Ill., focused on improving transparency around third-party sellers online, is getting the backing of Walgreens.

Four trade associations representing the dietary supplement industry have joined forces to urge Congress to provide legal clarity regarding the CBD marketplace.

Pharmacy organizations are urging the Senate Finance Committee to swiftly take action on DIR fee reform.

In a letter to the Trump administration, legislators noted that DIR fees on pharmacies participating in Part D grew by 45,000% between 2010 and 2017.

The Council for Responsible Nutrition recently praised two senators and two representatives for their work to introduce the SNAP Vitamin and Mineral Improvement Act

Among organizations and companies sharing their thoughts about cannabis and cannabis-derived products were the Food Marketing Institue, the National Cannabis Industry Association and manufacturer Functional Remedies.